Published in Curr Alzheimer Res on June 01, 2008
The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics (2008) 2.72
Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol Cell (2011) 1.49
Advances in translational bioinformatics: computational approaches for the hunting of disease genes. Brief Bioinform (2009) 1.27
Guiding protein aggregation with macromolecular crowding. Biochemistry (2008) 1.23
Protein disorder in the human diseasome: unfoldomics of human genetic diseases. BMC Genomics (2009) 1.11
Single molecule characterization of α-synuclein in aggregation-prone states. Biophys J (2010) 1.09
Insights into the regulation of intrinsically disordered proteins in the human proteome by analyzing sequence and gene expression data. Genome Biol (2009) 1.08
Competition between intramolecular and intermolecular interactions in an amyloid-forming protein. J Mol Biol (2009) 1.02
Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases. Chem Rev (2014) 0.98
The role of intrinsically unstructured proteins in neurodegenerative diseases. PLoS One (2009) 0.95
The intrinsically disordered N-terminal region of AtREM1.3 remorin protein mediates protein-protein interactions. J Biol Chem (2012) 0.92
Shedding light on protein folding landscapes by single-molecule fluorescence. Chem Soc Rev (2014) 0.89
At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to alpha-synuclein and prevents its fibrillation. J Mol Biol (2009) 0.88
In-silico prediction of disorder content using hybrid sequence representation. BMC Bioinformatics (2011) 0.87
Chain collapse of an amyloidogenic intrinsically disordered protein. Biophys J (2011) 0.87
Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN. Biochemistry (2008) 0.86
Use of a small peptide fragment as an inhibitor of insulin fibrillation process: a study by high and low resolution spectroscopy. PLoS One (2013) 0.85
High-throughput characterization of intrinsic disorder in proteins from the Protein Structure Initiative. J Struct Biol (2012) 0.82
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators. Front Mol Biosci (2014) 0.82
Aging and neurogenesis, a lesion from Alzheimer's disease. Aging Dis (2010) 0.82
Orthogonal high-throughput thermal scanning method for rank ordering protein formulations. AAPS PharmSciTech (2013) 0.81
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal. World J Diabetes (2015) 0.80
De novo design and experimental characterization of ultrashort self-associating peptides. PLoS Comput Biol (2014) 0.79
On the intrinsic disorder status of the major players in programmed cell death pathways. F1000Res (2013) 0.79
Computational modeling of the relationship between amyloid and disease. Biophys Rev (2012) 0.79
Discordant and chameleon sequences: their distribution and implications for amyloidogenicity. Protein Sci (2011) 0.79
Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants. Front Mol Neurosci (2012) 0.77
The SCHOOL of nature: II. Protein order, disorder and oligomericity in transmembrane signaling. Self Nonself (2010) 0.77
Suppression of amyloid fibrils using the GroEL apical domain. Sci Rep (2016) 0.77
Insights into the evolutionary features of human neurodegenerative diseases. PLoS One (2012) 0.76
Rapid Brownian Motion Primes Ultrafast Reconstruction of Intrinsically Disordered Phe-Gly Repeats Inside the Nuclear Pore Complex. Sci Rep (2016) 0.76
Unusual biophysics of immune signaling-related intrinsically disordered proteins. Self Nonself (2010) 0.76
Structural analysis of peptide-analogues of human Zona Pellucida ZP1 protein with amyloidogenic properties: insights into mammalian Zona Pellucida formation. PLoS One (2013) 0.76
Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation. Chem Commun (Camb) (2016) 0.75
DisoMCS: Accurately Predicting Protein Intrinsically Disordered Regions Using a Multi-Class Conservative Score Approach. PLoS One (2015) 0.75
Modulating the Effects of the Bacterial Chaperonin GroEL on Fibrillogenic Polypeptides through Modification of Domain Hinge Architecture. J Biol Chem (2016) 0.75
Inhibitory effect of corcin on aggregation of 1N/4R human tau protein in vitro. Iran J Basic Med Sci (2015) 0.75
Sensing Tryptophan Microenvironment of Amyloid Protein Utilizing Wavelength-Selective Fluorescence Approach. J Fluoresc (2017) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (2002) 19.36
Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol (2005) 17.63
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol (1999) 11.38
[URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science (1994) 10.94
From Levinthal to pathways to funnels. Nat Struct Biol (1997) 10.58
Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell (1993) 10.15
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A (1986) 10.13
Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol (2004) 10.13
High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci (2000) 9.85
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol (2004) 9.62
IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics (2005) 9.02
Intrinsic disorder and protein function. Biochemistry (2002) 8.54
Intrinsically disordered protein. J Mol Graph Model (2001) 8.54
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A (1998) 8.41
Intrinsically unstructured proteins. Trends Biochem Sci (2002) 7.96
Protein disorder prediction: implications for structural proteomics. Structure (2003) 7.93
Protein misfolding, evolution and disease. Trends Biochem Sci (1999) 7.73
Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem (1997) 7.62
Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins (2000) 7.61
The distribution of tau in the mammalian central nervous system. J Cell Biol (1985) 7.47
Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol (1997) 7.27
Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science (1996) 7.24
Sequence complexity of disordered protein. Proteins (2001) 6.97
Natively unfolded proteins: a point where biology waits for physics. Protein Sci (2002) 6.91
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry (1996) 6.47
Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell (1998) 6.24
Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science (2000) 6.16
The DISOPRED server for the prediction of protein disorder. Bioinformatics (2004) 5.98
GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res (2003) 5.90
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A (2000) 5.83
Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem (1998) 5.81
A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science (1991) 5.60
Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J (1996) 5.50
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med (1998) 5.49
FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics (2005) 5.44
Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J (2005) 5.36
Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature (2002) 5.32
Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell (1997) 5.24
The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol (1998) 5.20
Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell (1995) 5.16
Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell (1992) 5.11
Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci (2001) 4.92
Transcription factors that activate the Ultrabithorax promoter in developmentally staged extracts. Cell (1988) 4.87
Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol (2000) 4.76
Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci (2003) 4.75
Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71
Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol (1977) 4.60
Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci (1997) 4.57
Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol (1996) 4.54
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A (1987) 4.53
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem (1989) 4.43
Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol (1977) 4.42
Natively unfolded proteins. Curr Opin Struct Biol (2005) 4.39
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci (1988) 4.36
Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol (2001) 4.27
A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell (1998) 4.25
Prion protein biology. Cell (1998) 4.20
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics (2005) 4.18
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis (2002) 4.14
Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des (1998) 4.10
Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A (1997) 4.10
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci (1989) 4.01
Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci (1999) 3.92
NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett (1997) 3.90
Alzheimer's disease and Parkinson's disease. N Engl J Med (2003) 3.88
Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem (2004) 3.87
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A (2000) 3.86
Intrinsic disorder and functional proteomics. Biophys J (2006) 3.84
The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett (2005) 3.80
Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science (1995) 3.78
The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res (1992) 3.74
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1993) 3.73
Alzheimer's disease: genotypes, phenotypes, and treatments. Science (1997) 3.72
Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J (1999) 3.72
What does it mean to be natively unfolded? Eur J Biochem (2002) 3.70
Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta (2004) 3.69
The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci (2001) 3.65
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry (2000) 3.62
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet (1998) 3.62
In vitro transcription of the Drosophila engrailed gene. Genes Dev (1988) 3.62
Identification of two distinct synucleins from human brain. FEBS Lett (1994) 3.61
Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem (2001) 3.60
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit (2005) 3.57
Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci (1999) 3.57
Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci U S A (1998) 3.55
Amphipathic helix motif: classes and properties. Proteins (1990) 3.52
Predicting Protein Disorder for N-, C-, and Internal Regions. Genome Inform Ser Workshop Genome Inform (1999) 3.48
3'-End processing of pre-mRNA in eukaryotes. FEMS Microbiol Rev (1999) 3.47
Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform (2000) 3.47
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A (1997) 3.42
Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A (1997) 3.40
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol (2004) 3.37